News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2024 Shelley Wood April 03, 2024
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
Presentation THT 2023 A Novel Non-Invasive Multi-Sensor Medical Device For Measurement And Estimation Of Absolute Intracardiac Pressure, Enabling Early Detection And Ongoing Management Of Heart Failure Patients And Pulmonary Hypertension Presenter: Matthew Mace March 21, 2023
News Conference News ESC 2022 DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum Todd Neale August 27, 2022
News Daily News After COVID-19, Unvaccinated at Risk for Long-term CVD Complications Michael O'Riordan August 16, 2022
News Conference News ACC 2022 Seasonal, but No Year-round Help for HF With Flu Shots: IVVE Yael L. Maxwell April 03, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2022 Caitlin E. Cox April 01, 2022
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Conference News ESC 2021 SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI Michael O'Riordan August 27, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2020 Shelley Wood November 30, 2020
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020